FDA staff question Roche drug breast cancer data
by on Jul.16, 2010, under Health and Fitness
Two studies of Roche AG's blockbuster drug Avastin failed to show the same level of benefit for advanced breast cancer patients seen in an earlier trial, U.S. reviewers said in documents released on Friday.
View full post on Yahoo! Health News
